Clinical Evaluation for Post Bleaching Hypersensitivity Using Desensitizing Agent During In-office Bleaching
1 other identifier
interventional
36
1 country
1
Brief Summary
Evaluating the effect of a desensitizing agent on post-bleaching hypersensitivity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 19, 2016
CompletedFirst Posted
Study publicly available on registry
October 21, 2016
CompletedStudy Start
First participant enrolled
November 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 29, 2018
CompletedSeptember 18, 2019
September 1, 2019
10 months
October 19, 2016
September 16, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Post-bleaching hypersensitivity assessed using visual analogue scale
using visual analogue scale
one month
Secondary Outcomes (1)
Tooth color assessed using value-ordered VITA® Classical Shade Guide
one month
Study Arms (2)
ACP oral care geldesensitizing agent
EXPERIMENTALa desensitizing agent will be applied on tooth before and /or after bleaching.
glycrin
PLACEBO COMPARATORglycrin will be applied on tooth before and /or after bleaching.
Interventions
a desensitizing agent will be applied on tooth before and/or after bleaching
Eligibility Criteria
You may qualify if:
- Patients must show no signs of spontaneous dental pain.
- Male or female patients between the ages of 18 to 40.
- Patients with good general and oral health.
- Patients having six caries-free maxillaryanterior teeth without restorations on the labial surfaces.
- Patients should have central incisors determined to be shade C2 or darker
You may not qualify if:
- Patient with spontaneous dental pain.
- Patient with anterior restorations or non carious cervical lesion.
- Patient having severe internal tooth discoloration (tetracycline stains, fluorosis, pulpless teeth), and bruxism habits.
- Tempro-mandibular joint problems involving symptomatic pain.
- Patients taking analgesics that could alter their normal pain perception level.
- Pregnant or breast feeding women.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Faculty of dentistry Cairo university
Cairo, 11651, Egypt
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- researcher
Study Record Dates
First Submitted
October 19, 2016
First Posted
October 21, 2016
Study Start
November 1, 2017
Primary Completion
September 1, 2018
Study Completion
November 29, 2018
Last Updated
September 18, 2019
Record last verified: 2019-09
Data Sharing
- IPD Sharing
- Will not share